Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid, Rogier Hintzen, Martin Belkin et al.|The Lancet Neurology|2019

Cited by 185